Andrew Perry
Chemotherapy, surgical excision with a safe margin, and radiation are all used to treat bone and soft tissue sarcomas. Although good results have been recorded in individuals with non-metastatic sarcomas, the results in patients with metastatic or recurring sarcomas are still poor. New therapies or changes of conventional treatments are needed to combat metastatic or recurring sarcomas. Recent research and reviews on therapeutic targets, anticancer drugs, immunotherapy, and care in patients with bone and soft tissue sarcomas were featured in this special issue. Several studies and reviews of aberrant gene expression in bone and soft tissue sarcomas were featured in this special issue.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 